Beaird Harris Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-100
Closed -$15K – 720
2021
Q4
$15K Buy
+100
New +$13.5K 0.01% 356

Other funds holding TNDM

Beaird Harris Wealth Management's TNDM Position: Q1 2022 in Review

Beaird Harris Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 100 shares — an estimated $15K sold.

Beaird Harris Wealth Management first reported a position in TNDM in Q4 2021 and held it in 1 quarter. The position peaked at $15K in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Beaird Harris Wealth Management reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 100 Tandem Diabetes Care shares in Q1 2022, an estimated $15K.
  • Beaird Harris Wealth Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 1 quarter.
  • Beaird Harris Wealth Management's Tandem Diabetes Care position peaked at $15K in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Beaird Harris Wealth Management's 13F filing for Q1 2022, filed 27 May 2022.